Objective: To investigate the expression of autoantibodies to the angiotensin II type I receptor (AT1-AA) and endothelin-1 (ET-1) in pregnant women's blood and explore their correlation with the pathogenesis of preeclampsia.
Methods: Ninety pregnant women who delivered from June 2011 to December 2011 in the First Affiliated Hospital of Zhengzhou University were chosen as the study objects. They were divided into mild preeclampsia group (n = 30), severe preeclampsia group (n = 30) and normal group (control group, n = 30). The levels of AT1-AA and ET1 in maternal peripheral blood and umbilical cord blood were detected by ELISA, and the mRNA expression levels of AT1-AA and ET1 in placenta tissues were determined by reverse transcription (RT) PCR. Moreover, the correlation clinical indexes were detected and analysed.
Results: (1) The levels of AT1-AA and ET1 in maternal peripheral blood of preeclampsia [mild group: (114 ± 19) ng/L and (31 ± 9) ng/L, severe group: (145 ± 15) ng/L and (38 ± 10) ng/L] were both significantly higher than that of control group [(59 ± 5) ng/L, (17 ± 4) ng/L]. In addition, compared with mild group, the levels of AT1-AA and ET1 in severe group were significantly higher (P < 0.05). (2) The levels of AT1-AA and ET1 in umbilical cord blood of preeclampsia [mild group: (105 ± 14) ng/L and (35 ± 6) ng/L, severe group: (118 ± 14) ng/L and (40 ± 5) ng/L] were significantly higher than that of control group [(61 ± 12) ng/L, (24 ± 5) ng/L]. In addition, compared with mild group, the levels of AT1-AA and ET1 in severe group were significantly higher (P < 0.05). (3) The mRNA expression levels of AT1-AA and ET1 in placenta tissues of mild group (0.313 ± 0.039, 0.296 ± 0.028) and severe group (0.568 ± 0.052, 0.577 ± 0.046) were significantly higher than that in control group (0.198 ± 0.017, 0.137 ± 0.012), and the levels in severe group were significantly higher than that in mild group (P < 0.05). (4) There was an evident positive correlation between AT1-AA and ET1 levels of preeclampsia women's peripheral blood, umbilical cord blood and placenta (P < 0.05). (5) The level of AT1-AA in umbilical cord blood of preeclampsia pregnant women was positively correlated with S/D value of umbilical artery (P < 0.05), and negatively correlated with the weight of the birth and the placental (P < 0.05).
Conclusion: The AT1-AA in the blood of pregnant women plays an important role in promoting the generation and development of preeclampsia by increasing the ET1 secretion.
Download full-text PDF |
Source |
---|
Nitric Oxide
June 2019
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China; Beijing Key Laboratory of Metabolic Disorders Related Cardiovascular Diseases, Capital Medical University, Beijing, 100069, China. Electronic address:
Angiotensin II type 1 receptor autoantibodies (AT1-AA) cause endothelial-dependent smooth muscle relaxation disorder. It is well understood that impairment of the NO-cGMP signaling pathway is one of the mechanisms of endothelial-dependent smooth muscle relaxation disorder. However, it is still unclear whether AT1-AA induces endothelial-dependent smooth muscle relaxation disorder via the impairment of the NO-cGMP signaling pathway.
View Article and Find Full Text PDFCurr Pharm Biotechnol
February 2019
Department of Pharmacology & Toxicology, University of Mississippi Medical Center, Jackson, MS, United States.
Preeclampsia is the leading cause of death and morbidity worldwide for the mother and fetus during pregnancy. Preeclampsia does not only affect the mother and the baby during pregnancy, but can also have long-term effects, such as the increased risk of hypertension and cardiovascular disease on the offspring and the postpartum mother later in life. The exact cause of preeclampsia is unknown, but women with preeclampsia have elevated concentrations of agonistic autoantibodies against the angiotensin II type 1 receptor (AT1-AA).
View Article and Find Full Text PDFCurr Hypertens Rep
April 2018
Cardiovascular-Renal Research Center, University of Mississippi Medical Center, Jackson, MS, 39216, USA.
Purpose Of Review: Preeclampsia (PE) is a disorder of pregnancy typically characterized by new-onset hypertension and proteinuria after gestational week 20. Although preeclampsia is one of the leading causes of maternal and perinatal morbidity and death worldwide, the mechanisms of the pathogenesis of the disorder remain unclear and treatment options are limited. Placental ischemic events and the release of placental factors appear to play a critical role in the pathophysiology.
View Article and Find Full Text PDFSci Rep
January 2018
Department of Physiology, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China.
HELLP syndrome remains a leading cause of maternal and neonatal mortality and morbidity worldwide, which symptoms include hemolysis, elevated liver enzymes and low platelet count. The objective of this study was to determine whether HELLP is associated with AT1-AA. The positive rate and titer of AT1-AA in plasma from pregnant women were determined, and the correlation of AT1-AA titer with the grade of HELLP was analyzed.
View Article and Find Full Text PDFJ Taibah Univ Med Sci
December 2017
Division of Maternal-Fetal Medicine, Department of Obstetric and Gynecology, Faculty of Medicine-Brawijaya University/dr. Saiful Anwar-General Hospital, Malang, Indonesia.
Objectives: Preeclampsia affects 3%-8% of all pregnancies. Thymoquinone is the primary compound in black cumin () and may have potential therapeutic effects in preeclampsia. This research analyses the effects of a black cumin seed ethanol extract on angiotensin II type 1-receptor autoantibody (AT1-AA) serum levels and the expression of the endothelin-1 (ET-1) in the placenta in preeclampsia mouse model.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!